Evidence map›Paper›PMID 28720875›Full record

ArticleScientific reports2017

Ruthenium-conjugated chrysin analogues modulate platelet activity, thrombus formation and haemostasis with enhanced efficacy.

Divyashree Ravishankar, Maryam Salamah, Alda Attina, Radhika Pothi, Thomas M Vallance, Muhammad Javed, Harry F Williams, Eman M S Alzahrani, Elena Kabova, Rajendran Vaiyapuri and 6 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 50 citations in OpenAlex.

  1. Tailoring the biological activity of oxorhenium(V) complexes through Chrysin ligand functionalization.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. The Cardiovascular Protective Effects of Chrysin: A Narrative Review on Experimental Researches.Cardiovascular & hematological agents in medicinal chemistry · 2019
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 2 institutions in 2 countries.

Divyashree RavishankarSchool of Pharmacy, University of Reading, Reading, UK.
Maryam SalamahSchool of Pharmacy, University of Reading, Reading, UK.
Alda AttinaSchool of Pharmacy, University of Reading, Reading, UK.
Radhika PothiSchool of Pharmacy, University of Reading, Reading, UK.
Thomas M VallanceSchool of Pharmacy, University of Reading, Reading, UK.
Muhammad JavedSchool of Pharmacy, University of Reading, Reading, UK.
Harry F WilliamsSchool of Pharmacy, University of Reading, Reading, UK.
Eman M S AlzahraniSchool of Pharmacy, University of Reading, Reading, UK.
Elena KabovaSchool of Pharmacy, University of Reading, Reading, UK.
Rajendran VaiyapuriSchool of Pharmacy, University of Reading Malaysia, Johar, Malaysia.
Kenneth ShanklandSchool of Pharmacy, University of Reading, Reading, UK.
Jonathan GibbinsInstitute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading, UK.
Katja StrohfeldtSchool of Pharmacy, University of Reading, Reading, UK.
Francesca GrecoSchool of Pharmacy, University of Reading, Reading, UK.
Helen M I OsbornSchool of Pharmacy, University of Reading, Reading, UK. h.m.i.osborn@reading.ac.uk.
Sakthivel VaiyapuriSchool of Pharmacy, University of Reading, Reading, UK. s.vaiyapuri@reading.ac.uk.
University of Reading · GBOpen University Malaysia · MY

Funding

British Heart Foundation FS/16/65/32489British Heart Foundation PG/11/125/29320British Heart Foundation PG/16/64/32311British Heart Foundation RG/09/011/28094Wellcome Trust
6 · The paper itself

Abstract

The constant increase in cardiovascular disease rate coupled with significant drawbacks of existing therapies emphasise the necessity to improve therapeutic strategies. Natural flavonoids exert innumerable pharmacological effects in humans. Here, we demonstrate the effects of chrysin, a natural flavonoid found largely in honey and passionflower on the modulation of platelet function, haemostasis and thrombosis. Chrysin displayed significant inhibitory effects on isolated platelets, however, its activity was substantially reduced under physiological conditions. In order to increase the efficacy of chrysin, a sulfur derivative (thio-chrysin), and ruthenium-complexes (Ru-chrysin and Ru-thio-chrysin) were synthesised and their effects on the modulation of platelet function were evaluated. Indeed, Ru-thio-chrysin displayed a 4-fold greater inhibition of platelet function and thrombus formation in vitro than chrysin under physiologically relevant conditions such as in platelet-rich plasma and whole blood. Notably, Ru-thio-chrysin exhibited similar efficacy to chrysin in the modulation of haemostasis in mice. Increased bioavailability and cell permeability of Ru-thio-chrysin compared to chrysin were found to be the basis for its enhanced activity. Together, these results demonstrate that Ru-thio-coupled natural compounds such as chrysin may serve as promising templates for the development of novel anti-thrombotic agents.

Indexed as

AnimalsBiological AvailabilityBlood PlateletsDisease Models, AnimalFibrinolytic AgentsFlavonoidsHemostasisHumansMicePlatelet ActivationRutheniumThrombosischrysinFibrinolytic AgentsFlavonoidsRuthenium

Identifiers

PMID28720875
PMCPMC5515887
OpenAlexW2736123661

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.